Your browser doesn't support javascript.
loading
Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia.
Hughes, Timothy P; Laneuville, Pierre; Rousselot, Philippe; Snyder, David S; Rea, Delphine; Shah, Neil P; Paar, David; Abruzzese, Elisabetta; Hochhaus, Andreas; Lipton, Jeffrey H; Cortes, Jorge E.
Afiliação
  • Hughes TP; Cancer Theme, SAHMRI, Division of Haematology, SA Pathology, University of Adelaide, South Australia, Australia.
  • Laneuville P; McGill University Health Centre, Montreal, QC, Canada.
  • Rousselot P; Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Le Chesnay, France.
  • Snyder DS; City of Hope, Duarte, CA, USA.
  • Rea D; Service d'Hématologie Adulte, Hôpital Saint-Louis, Paris, France.
  • Shah NP; UCSF School of Medicine, San Francisco, CA, USA.
  • Paar D; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Abruzzese E; Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
  • Hochhaus A; Hematology/Oncology, Universitätsklinikum Jena, Germany.
  • Lipton JH; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Cortes JE; University of Texas MD Anderson Cancer Center, Houston, TX, USA jcortes@mdanderson.org.
Haematologica ; 104(1): 93-101, 2019 01.
Article em En | MEDLINE | ID: mdl-30093398

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Derrame Pleural Maligno / Dasatinibe Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Derrame Pleural Maligno / Dasatinibe Idioma: En Ano de publicação: 2019 Tipo de documento: Article